Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Molecular Oncology|August 1, 2012
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institutionNuno Cerveira, Susana Lisboa, Cecília Correia, et al.Pediatric Blood & Cancer|February 27, 2021
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomabRosemary Sutton, Luciano Dalla Pozza, Seong Lin Khaw, et al.British Journal of Haematology|October 3, 2012
CBL mutations do not frequently occur in paediatric acute myeloid leukaemiaEva A Coenen, Emma M C Driessen, C Michel Zwaan, et al.Nature Communications|October 6, 2023
Distinct and targetable role of calcium-sensing receptor in leukaemiaRaquel S Pereira, Rahul Kumar, Alessia Cais, et al.Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.Blood|September 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic featuresClara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez, et al.Translational Oncology|March 17, 2019
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic LeukemiaBruno A Lopes, Claus Meyer, Thayana C Barbosa, et al.Blood|November 4, 2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers, Eva A Coenen, Brian V Balgobind, et al.Blood|July 19, 2021
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike proteinAndreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.Pageof 16